undamentalytics Newsletter
Sign in

Iridex Corp income statement

In fiscal 2025, Iridex Corp reported revenue of $52.7m, up 8.2% on the year before, operating income of −$2.6m (a -4.9% margin) and net income of −$4.4m, or −$0.26 per diluted share. Every line below comes from the company's 10-K and 10-Q filings; column headings link to the filing.

Income statement

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year2009Jan 20102010Jan 20112011Dec 20112012Dec 20122013Dec 20132014Jan 20152015Jan 20162016Dec 20162017Dec 20172018Dec 20182019Dec 20192020Jan 20212021Jan 20222022Dec 20222023Dec 20232024Dec 20242025Jan 2026LTMJul 2026
Revenue313233343843424642434336545752495352
Cost of revenue161617182021222526252621313230293333
Gross profit151616161921202116171816232522201919
Research and development344445555443777544
Selling and marketing77788891015171512151816131010
General and administrative44455668910879891087
Operating income112−1330−3−13−13−9−7−8−8−10−8−3−3
Interest expense———————————————00—
Income before tax222−0210−3−13−13−9−6−5−7−9−9−4−3
Income tax000−00−9−09−0000000000
Net income33312100−12−13−13−9−6−5−8−10−9−4−4
Diluted EPS—$0.30$0.26$0.16$0.22$0.97$0.05−$1.15−$1.11−$1.05−$0.64−$0.46−$0.34−$0.47−$0.59−$0.54−$0.26−$0.21
Diluted shares (average)10m10m10m9m10m10m10m10m12m12m14m14m15m16m16m16m17m17m
EBITDA212−0331−2−12−12−8−6−7−7−9−8−2−2

EBITDA is operating income plus depreciation and amortisation. EPS and share counts are restated for stock splits. A dash means the company did not report the line for that period; expense lines are shown as reported, so they need not add up to the totals when a company reports other items between them.

Compare with peers

Head to head: IRIX vs SENSAPYX vs IRIXCLPT vs IRIX

More: Health Care Equipment stocks compared, Health Care sector, rankings of US companies

Figures from Iridex Corp's SEC filings (10-K and 10-Q), retrieved October 29, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Iridex Corp.